Disrupted in schizophrenia 1 (DISC1) L100P mutants have impaired activity-dependent plasticity in vivo and in vitro by Molinos, I et al.
OPEN
ORIGINAL ARTICLE
Disrupted in schizophrenia 1 (DISC1) L100P mutants have
impaired activity-dependent plasticity in vivo and in vitro
D Tropea1,2,3, I Molinos1,2, E Petit4, S Bellini1,2, I Nagakura3, C O’Tuathaigh4, L Schorova1,2, KJ Mitchell5, J Waddington4, M Sur3, M Gill1,2
and AP Corvin1,2
Major neuropsychiatric disorders are genetically complex but share overlapping etiology. Mice mutant for rare, highly penetrant risk
variants can be useful in dissecting the molecular mechanisms involved. The gene disrupted in schizophrenia 1 (DISC1) has been
associated with increased risk for neuropsychiatric conditions. Mice mutant for Disc1 display morphological, functional and
behavioral deﬁcits that are consistent with impairments observed across these disorders. Here we report that Disc1 L100P mutants
are less able to reorganize cortical circuitry in response to stimulation in vivo. Molecular analysis reveals that the mutants have a
reduced expression of PSD95 and pCREB in visual cortex and fail to adjust expression of such markers in response to altered
stimulation. In vitro analysis shows that mutants have impaired functional reorganization of cortical neurons in response to selected
forms of neuronal stimulation, but there is no altered basal expression of synaptic markers. These ﬁndings suggest that DISC1 has a
critical role in the reorganization of cortical plasticity and that this phenotype becomes evident only under challenge, even at early
postnatal stages. This result may represent an important etiological mechanism in the emergence of neuropsychiatric disorders.
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INTRODUCTION
The major neuropsychiatric disorders (for example, schizophrenia,
bipolar disorder, major depressive disorder, autism spectrum
disorder and attention deﬁcit hyperactivity disorder) are substan-
tially heritable and are of genetically complex etiology. Their
etiology is polygenic, with evidence for a spectrum from common
but small effects to rare, more highly penetrant mutations,
together with environmental risk factors.1 Although age at onset
varies across these disorders, from childhood (autism spectrum
disorder, attention deﬁcit hyperactivity disorder) to young
adulthood (most cases of schizophrenia, major depressive
disorder, bipolar disorder), they share not only overlapping
symptoms and environmental risk factors, but also molecular
etiology.2 Recent ﬁndings suggest that dysregulation of synaptic
function and plasticity in cortex and hippocampus are related to
cellular and behavioral alterations observed in neuropsychiatric
disorders.3 Here, we show that a putative risk gene, disrupted in
schizophrenia 1 (DISC1), implicated across neuropsychiatric
disorders regulates not only the initial development of neuronal
circuitry, but also synaptic plasticity during postnatal development
in vivo. This role in activity-dependent reorganization of neural
circuitry may explain how risk genes contribute to a range of
phenotypic outcomes inﬂuenced by different environmental
stimuli.
There is broad agreement that studying rare, highly penetrant
risk mutations in appropriate cellular and animal models can shed
light on the molecular mechanisms and neuronal circuit
dysregulation contributing to neuropsychiatric disorders.4 DISC1
was originally identiﬁed at the breakpoint of a balanced
chromosomal translocation co-segregating with mental disorders
in a large Scottish kindred.5 The strongest evidence indicated a
broad-risk phenotype that includes schizophrenia and a range of
neuropsychiatric disorders,6,7 but the interpretation of these data
has proved more challenging.8,9 This gene, and in particular the
initially reported mutation, has been the subject of much
functional work.10 Systematic investigation suggests that DISC1
is present in several cellular compartments, including synapses,
where it interacts with a wider molecular network to mediate
cellular and synaptic function.10,11 Recent studies on patient-
derived iPSCs with a mutation in DISC1 conﬁrmed a cellular
phenotype consistent with synaptic dysregulation.12 Disruption of
DISC1’s molecular interactions induces cellular phenotypes similar
to those observed in neuropsychiatric disorders, hence speciﬁc
DISC1-cofactor interactions may be a target for the treatment of
mental disorders.13 One of the proven interactions of DISC1 is with
phosphodiesterase 4B (PDE4B) and GSK3β, which also are risk
factors for schizophrenia.14 Mouse models that disrupt these
interactions (L100P mice) have been generated and show
impairment in working memory15 and altered exploratory and
habituation behavior,16 as well as deﬁcits in brain size and
neuronal migration.17 The DISC1–PDE4B interaction modulates the
metabolism of cAMP, which is a second messenger important in
neuronal signal transduction. cAMP-activated signaling deter-
mines the phosphorylation of CREB, which acts as a transcription
factor for genes involved in neuronal and synaptic function.
Indeed, CREB signaling is an important mediator of activity-
dependent plasticity in health and disease.18 GSK3β controls
molecular pathways dysregulated in several neuropsychiatric
disorders,19 and in particular psychosis.20 Although there is
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evidence for involvement of DISC1 in synaptic transmission in
several brain areas,21,22 functional in vivo validation in response to
long-term changes is still lacking. Here, we evaluate the ability of
Disc1 mutant mice to undergo activity-dependent reorganization
of circuitry in vitro and in vivo. For the in vivo analysis, we use
ocular dominance plasticity, an established paradigm to investi-
gate reorganization of circuits in health and disease.23 For the
in vitro analysis, we use primary neuronal cultures derived from
homozygous L100P mutants and wild-type (WT) mice, and
measure the expression of synaptic markers under basal condi-
tions and after stimulation. We report that in vivo L100P mice fail
to reorganize cortical circuits in response to long-term stimuli and
that in vitro L100P cells have an impaired regulation of synaptic
proteins in response to activity. In addition, we show that
functional alteration is because of a dysregulation of CREB activity
consequent to stimulation.
MATERIALS AND METHODS
Animal studies were performed according to DCM regulations in each
country (TCD-Ireland—license B100/4358 and MIT-USA). The DISC1 L100P
mutants were provided by the RIKEN BRC through the National Bio-
Resource Project of the MEXT, Japan. For preparation and immunocyto-
chemistry, we used the methods previously described.24 Our primary
neuronal cultures include neurons and glial cells, and 20% of neurons are
gabaergic (Supplementary Figure 1). Disc1 is expressed in WT and L100P
cultures and does not show a trend in speciﬁc neuronal type. For
functional imaging and immunohistochemistry, we used the methods
described in our past publications.25,26 For detailed protocols in vitro and
in vivo, see Supplementary Information.
Choice of DISC1 mutant and colony management
As DISC1 has proven to be a candidate gene for neuropsychiatric disorders,
several mouse mutants have been generated with different alterations in
the gene. Considering the multiple interactors of DISC1, it is reasonable to
expect that different mutants will have different molecular and behavioral
phenotypes, according to the pathway affected.14 The mice were
maintained on a C57BL6 background (eight backcrosses).
The ENU-generated mouse of our choice has a single nucleotide
mutation that affects the binding region of Disc1 with Pde4b and Gsk3β,
which are two molecules involved in the pathology of schizophrenia. A
recent work of Arime et al.27 shows that these mice have multiple ENU-
induced mutations and that they sum up to produce the phenotype.
Several studies characterized the behavioral phenotype of these mice.
They demonstrate several phenotypes relevant to schizophrenia including
impaired social behavior27 and hyperactivity in a novel environment.16,28
Speciﬁcally, Walsh et al.16 replicated16 the hyperexploratory phenotype
ﬁrst reported by Clapcote et al.15 As reported by other authors,28 they
failed to replicate the prepulse inhibition deﬁcits reported for DISC1 L100P
mutants in the original15 paper. Several studies also report morphological
differences, such as reduced brain volume.15 It is of relevance that L100P
mice do not have signiﬁcant differences in Disc1 protein expression, but
they show reduced expression of its interactors.14,27 Consistent with these
ﬁndings, Walsh et al.16 isolated Disc1 from WT and L100P striatum lysates
and found that the interaction with Gsk3β was signiﬁcantly reduced by the
L100P mutation in our study. Altogether, these results show that L100P
mice have molecular, behavioral and morphological deﬁcits that are
consistent with alterations observed in schizophrenia and other neuro-
psychiatric disorders, and that they are a valid model to study the
biological function of Disc1 in such conditions.
RESULTS
L100P mutants show impaired ability to respond to changes in
neuronal activity in vivo
There is evidence that DISC1 is involved in synaptic function.10 To
determine whether brain circuitry in L100P mice properly
responds to neuronal stimulation in vivo, we tested the ability of
these mutants to respond to altered sensory stimulation in visual
cortex using the Ocular Dominance Plasticity paradigm. We ﬁrst
conﬁrmed that the mice have an intact visual system and respond
to visual stimulation, using the visual cliff test (Supplementary
Figure 2). We evaluated, using optical imaging of intrinsic signals,
the extent of cortical activity and map organization in L100P
mutants versus controls. We ﬁnd that, compared with age-
matched controls, mutants do not show any impairment in
cortical activation (WT ΔR/R= 4.2 ± 0.5 × 10− 3; L100P ΔR/
R= 5.3 ± 0.5 × 10− 3) or in the formation of cortical maps (WT
scatter = 0.13 ± 0.01; L100P ΔR/R= 0.097 ± 0.001).
We then tested how L100P mutants respond to sensory
stimulation by measuring the ability of visual circuitry to
reorganize in response to sensory deprivation using the ocular
dominance index (ODI; Supplementary Figure 3). We ﬁnd that
during the critical period, deprivation of the dominant eye
(monocular deprivation (MD)) induces the expected change in
ODI in WT (ODI_WT_C= 0.15 ± 0.04, N= 9; ODI_WT_MD=
− 0.13 ± 0.06, N= 12; Mann–Whitney (MW) = 0.0014). However,
the same protocol does not elicit any signiﬁcant change in L100P
mutants (ODI_L100P_C = 0.18 ± 0.07, N= 6; ODI_L100P_MD=0.03
± 0.25, N= 6; MW=0.13; Figure 1), showing that, although L100P
Figure 1. L100P mice have altered response to changes in sensory
deprivation. Monocular deprivation induces a signiﬁcant shift in
ocular dominance index (ODI) in WTmice (a–c) but not in L100P mice
(d–f). Plots of ocular dominance index in WT (b) and L100P mice (e)
represent the overall contribution of both eyes in the reorganization
of the circuitry; for details, see Supplementary Figure 1. (c and f)
These panels report the individual contribution of contralateral
(contra) and ipsilateral (ipsi) eyes in control (diamonds) and mono-
cularly deprived (MD—triangles) mice, each point has the coordinates
of contralateral eye (x) and ipsilateral eye (y). The ocular dominance
shift after MD is visible in WT (c), but not in L100P mice (f). *Indicates
statistically signiﬁcant. Scale bar, 0.5 mm. WT, wild type.
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mutants retain normal basal visual abilities, they do not manifest
the signiﬁcant shift in ocular dominance evident in WT mice.
These results show that L100P mutants are impaired in respond-
ing to changes in sensory stimulation in vivo.
Molecular pathways mediating activity-dependent response are
altered in L100P mutant mice in vivo
To establish the molecular mechanisms that underlie the inability
of circuits to reorganize in response to MD, we performed
immunohistochemistry on visual cortical sections where ocular
dominance plasticity had been induced. We (1) measured the
basal expression levels of proteins involved in synaptic function
and activation of PCREB signaling, and (2) investigated protein
levels in response to deprivation (Figure 2). We reasoned that the
most signiﬁcant changes should be observed in the contralateral
visual cortex, as this area receives mostly inputs from the
deprived eye.
First, we examined the expression of PSD95 and synapsin (SYN).
We ﬁnd that there is a signiﬁcant (60%) reduction in basal levels of
PSD95 immunostaining in the visual cortex of mutant mice
compared with controls (PSD95_WT_control (n= 9; N= 3) average
= 1.00 ± 0.05; PSD95_L100P_control (n= 10; N= 3) average
= 0.42 ± 0.08; MW=0.0003; Figure 2). By inducing ocular dom-
inance plasticity, we ﬁnd, as expected, a decrease (30%) in PSD95
immunostaining in the contralateral visual cortex of WT
(PSD95_WT_control (n= 10; N= 3) average = 1.00 ± 0.04;
PSD95_WT_MD (n= 5; N= 3) average = 0.52 ± 0.16; MW=0.01;
Figure 3a–f). This result is driven by a signiﬁcant reduction in
staining from the monocular portion of the contralateral cortex,
which receives inputs from the deprived eye only (Figure 2,
Supplementary Figure 3; 50%; MW=0.01). In mutants, there are no
signiﬁcant changes in PSD95 immunostaining in response to
ocular dominance plasticity, even when we consider only the
areas that receive input exclusively from the deprived eye
PSD95_L100P_control (n= 8; N= 3) average = 1.00 ± 0.15;
PSD95_L100P_MD (n= 7; N= 3) average = 0.94 ± 0.23; MW=NS
(not signiﬁcant).
Although the expression of PSD95 immunostaining is altered,
we do not ﬁnd any signiﬁcant change in the expression levels of
SYN in WT versus L100P mutant mice and in the response to MD,
in either genotype, even considering the monocular area of the
deprived section. The unaltered expression of SYN suggests that
there are mechanisms which counterbalance activity-related
changes at the level of excitatory postsynaptic structures, so that
the total number of connections is not altered.
As other L100P mutants have altered PCREB expression,29 and
CREB phosphorylation is important for visual cortical plasticity, we
checked whether impairment in CREB activation is present in
visual cortical sections and if the changes in CREB activation
induced by MD are consistent in WT and mutant animals. The
basal expression of PCREB in the visual cortex is reduced (70%) in
L100P mutants compared with the control levels (PCREB_WT
(n= 244, N= 3) average = 1.00 ± 0.02 (s.e.), PCREB_L100P (n= 135,
N= 3) average = 0.35 ± 0.03, MW=0.0001; Figure 2b). MD induces
a signiﬁcant reduction in PCREB immunostaining in WT visual
cortex (WT_control (n= 375; N= 3) average = 1.00 ± 0.02 (s.e.);
WT_MD (n= 178; N= 3) average 0.62 ± 0.02 (s.e.), MW=0.0001,
Figure 2). The same protocol does not induce any change in the
contralateral cortex of the mutants (L100P_control (n= 135; N= 3)
average = 1.00 ± 0.06; L100P_MD (n= 61; N= 3) average
= 0.95 ± 0.10. MW=NS; Figure 2). Note that although MD does
not lead to any signiﬁcant change with respect to basal levels of
the mutants, PCREB immunostaining is still signiﬁcantly lower
(30%) with respect to the level observed in the deprived cortex of
WT (WT_MD_contralateral = 0.80 ± 0.04; mut_MD_contralateral
= 0.50 ± 0.03; MW=0.0001). These results show that L100P
mutants have abnormal activation of CREB signaling in response
to altered sensory stimulation in vivo.
Figure 2. PSD95 and PCREB expression levels in WT L100P mice. (a)
Measurements of PSD95 immunostaining in visual cortex sections of
WT and L100P mice: the expression levels are signiﬁcantly lower in
the mutant. (b) The density of PCREB immunostaining signiﬁcantly
increases in WT but not L100P in visual cortex sections. (c–v)
Immunostaining for PSD95 (c–l) shows a signiﬁcant reduction of
PSD95 expression in the deprived region of the visual cortex of WT
(g), but not L100P (l) mice after monocular deprivation (MD).
Similarly, PCREB expression (m–v) is signiﬁcantly decreased in WT (q)
but not L100P mice (v). Scale bar (g–j), 80 μm. *Indicates statistically
signiﬁcant. WT, wild type.
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Figure 3. L100P mice do not show changes in PSD95 and synapsin expression after neuronal stimulation. Immunostaining for PSD95 and
MAP2 (a–h, s and t) show a signiﬁcant increase of PSD95 expression in the dendrites of primary neuronal cultures from WT, but not L100P
mice after long-term potentiation (LTP) stimulation. Similarly, synapsin (SYN) expression is signiﬁcantly increased in WT (i–l, q) but not L100P
mice (m–p, r) after stimulation. Scale bar ﬁgures, 40 μm; scale bar blow-out, 10 μm. *Indicates statistically signiﬁcant. WT, wild type.
Table 1. Basal level of expression of PSD95 and synapsin in WT and L100P animals
Antigen n (cells) N (animals) Immunostaining s.e. n (neurites) Rel puncta s.e.
PSD95-WT 15 3 1 0.01 20 0.22 0.02
SYN-WT 15 3 1 0.01 20 0.07 0.01
PSD95-L100P 14 3 1.1 0.01 20 0.22 0.02
SYN-L100P 14 3 0.9 0.02 20 0.15 0.01
Abbreviations: SYN, synapsin; WT, wild type.
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L100P mutant neurons show impaired reactivity to neuronal
stimulation in vitro
Our data in vivo show that L100P mutants are unable to respond
properly to neuronal stimulation. To study synaptic plasticity at
early stages of postnatal development, we prepared primary
cellular cultures from the cortex of L100P mutants and WT
littermates at P0–P1. We challenged the cultures with long-term
potentiation (LTP) and long-term depression (LTD), to reproduce
the phenomena observed in vivo, using the ocular dominance
plasticity paradigm.30 We observe no signiﬁcant differences in the
basal immunostaining of presynaptic (SYN) and postsynaptic
(PSD95) markers between DISC1 mutants and WT littermates
(Supplementary Figure 4, Table 1). However, when we stimulated
the cells for LTP, the cultures derived from these two genotypes
reacted differently. Stimulation elicited a signiﬁcant (25%) increase
in immunostaining of both PSD95 and SYN in WT, but no changes
in protein expression are present in L100P mutant mice. Detailed
results are reported in Table 1 and showed in Figure 3.
We tested whether the increase in expression of synaptic
markers in WT is because of an increase in the number or in the
size of the synapses. Using particle analysis of PSD95 immunos-
taining, we ﬁnd that the increase is because of enrichment in the
number of puncta, rather than an increase in synapse size
(Supplementary Figure 4, Table 2), suggesting that LTP stimulation
induces an increase in the number of excitatory synapse in WT but
not in mutants. No changes were observed in the pattern of SYN
puncta, P-value MW=0.54. At the basal level, there is no difference
in the PSD95 and SYN puncta between WT and L100P (Table 2).
To analyze the overlapping of presynaptic and postsynaptic
markers and determine the presence of synapses, we analyzed the
overlapping of the two different ﬂuorophores (red for SYN and
green for PSD95) and we compared the amount of yellow staining
(overlapping areas) in WT versus L100P. The amount of over-
lapping should correlate with the number of synapses. We did not
ﬁnd a signiﬁcant difference in the amount of functional synapses
between WT and mutants, although the L100P show a reduced
overlapping. (Colocalization number: WT-basal = 0.46 ± 0.02, WT-
LTP = 0.47 ± 0.02, n= 16 cells, N= 3 animals; L100P-basal
= 0.35 ± 0.03, L100-LTP = 0.36 ± 0.03, n= 14 cells, N= 3 animals;
P-value = 0.5; WT-basal = 0.5 ± 0.02, WT-LTD = 0.4 ± 0.04, n= 16
cells, N= 3 animals; L100P-basal = 0.5 ± 0.02, L100-LTD
= 0.5 ± 0.02, n= 16 cells, N= 3 animals).
We then investigated the molecular mechanisms underlying the
inability of L100P mutants to react to stimulation. According to the
literature,15 these mutants have a decreased ability to bind Pde4B
and this impacts on the metabolism of cAMP. As cAMP is an
important modulator of activity-dependent cellular response and
mediates CREB-dependent activation of transcription,31 we
reasoned that in mutant-derived neurons there should be an
altered reduced concentration of PCREB, which corresponds to the
activated form of CREB. Indeed, we ﬁnd that after 8 days in vitro in
regular culture conditions, L100P mutants evidence 50% less
PCREB immunostaining compared with WT: PCREB_WT (n= 159,
N= 2) average = 1.00 ± 0.03, PCREB_L100P (n= 110, N= 2) average
= 0.46 ± 0.02 (Supplementary Figure 5). Neuronal stimulation
induces signiﬁcant CREB activation in WT, but not in L100P mice,
suggesting that these mutants are impaired in responding to
stimulation via CREB activation WT_control (n= 204; N= 3)
average = 1.00 ± 0.03; WT_LTP (n= 142; N= 3) average
= 1.48 ± 0.07; WT_LTP L100P_control (n= 199; N= 5) average
= 1.00 ± 0.02; WT_LTP L100P_LTP (n= 68; N= 5) average
= 1.00 ± 0.10 (Figure 4).
Interestingly, another form of stimulation: LTD did not cause
any change in any of the markers tested (Table 3). At a later time
in cultures (15–20 days in vitro), we did not observe similar
phenotype, suggesting that this deﬁcit is evident at the time of
synapses’ formation.
Altogether, our analysis in vitro and in vivo shows that L100P
mutants have an abnormal response to neuronal stimulation, and
that impairment at the synaptic level is correlated with reduced
PCREB, and as a consequence, decreased PCREB-mediated
signaling.
L100P mutants have altered levels of DISC1-interactors
In an attempt to clarify the molecular mechanisms that lead to the
unpaired activity-dependent plasticity in L100P mutants, we
performed immunohistochemistry for Pde4B and cAMP in adult
L100P mice in different brain areas: prefrontal cortex, visual cortex,
hippocampus and cerebellum. We ﬁnd an overall signiﬁcant
increase of immunostaining in Pde4B and a nonsigniﬁcant trend
for reduced cAMP staining (Figure 5).
Table 2. Immunostaining and puncta analysis of LTP-treated and control cultures
Genotype Treatment Antigen n (cells) N (animals) Average s.e. Neurites Rel puncta s.e.
WT Control PSD95 40 3 1 0.08 40 0.14 0.02
WT LTP PSD95 36 3 1.3 0.03 40 0.19 0.02
L100P Control PSD95 68 5 1 0.01 57 0.11 0.01
L100P LTP PSD95 68 5 0.83 0.05 57 0.11 0.01
WT Control SYN 40 3 1 0.1 37 0.12 0.01
WT LTP SYN 37 3 1.7 0.2 37 0.19 0.02
L100P Control SYN 68 5 1 0.03 64 0.15 0.02
L100P LTP SYN 68 5 1 0.02 68 0.14 0.01
Abbreviations: LTP, long-term potentiation; SYN, synapsin; WT, wild type.
Figure 4. Activation of CREB in response to stimulation is impaired
in L100P mice in vitro. (a–c) Neuronal stimulation in cultures derived
from WT animals lead to a signiﬁcant increase in the expression of
activated creb (PCREB), whereas no effect is present in cultures
derived from L100P mice (d–f). *Indicates statistically signiﬁcant.
Scale bar, 40 μm. LTP, long-term potentiation; WT, wild type.
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As the speciﬁc mutation should impact cAMP metabolism and
ultimately the activation of CREB signaling, we measured the
levels of CREB and PCREB in nuclear fractions from L100P mutant
and WT brains. We found comparable levels of both proteins
between mutants and WT in whole-brain extracts and across
different brain sections, however, there is a decreased CREB and
PCREB immunostaining in the prefrontal cortex, (N= 2 animals,
n= 4 sections, CREB WT = 1± 0.16, L100P=m=0.57 ± 0.18; PCREB
WT = 1± 0.12, L100P = 0.55 ± 0.12) an area directly involved in
working memory and neuropsychiatric conditions. In addition, we
performed quantiﬁcation of Gsk3β in whole-brain extracts, and we
found a signiﬁcant reduction of Gsk3β immunostaining in adults
(WT= 1 ± 0.02; L100P = 0.2 ± 0.05; N= 6 animals, P-value = 0.01;
Supplementary Figure 6). We conﬁrmed a reduced immunostain-
ing for Gsk3β also in brain extracts immunoprecipitated for Disc1
(Walsh et al., 2012, unpublished data), suggesting that the overall
decrease in Gsk3β can be either due to a reduced overall
concentration of the protein or to a reduced interaction with
Disc1.20 In summary, the mutation in Disc1 protein, determines
changes in Disc1-mediated pathway and in the concentration of
Disc1 interactors Pde4B and Gsk3β.
L100P mutants have altered expression of cellular and synaptic
markers during development
In an attempt to clarify the developmental expression of synaptic
markers in vivo, we performed protein expression analysis in brain
extracts from WT and L100P mice at different ages: synaptic
formation (P8–10), synaptic pruning (P30–40), and adulthood
(above P60). For the analysis of synaptic proteins, we isolated
synaptoneurosomes from total brain extracts and we measured
the expression of presynaptic (SYN) and postsynaptic (PSD95)
markers. We ﬁnd that the expression of SYN in WT versus L100P
mutants has a trend which is dependent on the developmental
stage: the expression at P8–10 SYN levels in mutants was more
than twofold higher than in age-matched controls
(Supplementary Figure 7; P8–10 WT= 1± 0.095, L100P = 1.4 ± 0.13,
N= 12 animals, P-value = 0.01), while at P30–40 the mutants show
35% reduction in SYN levels (P30 WT= 1± 0.1, L100P = 0.62 ± 0.2,
N= 12 animals, P-value = 0.4) and more than 40% reduction in
adulthood (P60 WT= 1± 0.03, L100P= 0.58 ± 0.08, N= 12 animals,
P-value = 0.01). The expression of PSD95 follows a different
developmental trend: at P8–10, there are no signiﬁcant differences
in the expression of PSD95 in WT and mutants (although there is a
20% increase in mutants versus WT: P30 WT= 1± 0.9, L100P= 1.2
± 0.1, N= 9 animals, P-value = 0.4). Expression of PSD95 is
signiﬁcantly reduced in mutants versus WT at P30–40 (WT= 1±
0.06, L100P = 0.7 ± 0.7, N= 9 animals, P-value = 0.01) while P60
brains express comparable levels of the protein (WT= 1± 0.12,
L100P= 0.96 ± 0.11, N= 12 animals; Supplementary Figure 7).
In summary, we ﬁnd that the expression pattern of synaptic
proteins changes during development, with an unexpected
increase in SYN in mutants versus WT at P8–10, and a progressive
decrease at the following developmental stages.
As the speciﬁc mutation should impact cAMP metabolism and
ultimately the activation of CREB signaling, we measured the
levels of CREB and PCREB in nuclear fractions from L100P mutant
and WT brains. We found comparable levels of both proteins
between mutants and WT in whole-brain extracts at all postnatal
ages. In the same preparation, we conﬁrmed a signiﬁcant
reduction of Gsk3β immunostaining in adults (WT = 1± 0.02;
L100P= 0.2 ± 0.05; N= 6 animals, P-value = 0.01). In summary,
the activation of cellular pathways between WT and L100P
mutants decreases over development.
DISCUSSION
The main outcome of this study is that stimulation challenges
reveal deﬁciencies in mutants for risk genes of neuropsychiatric
disorders, even at an early stage of postnatal development, and
the impairments become evident only in response to a speciﬁc
challenge.
Highly penetrant genetic mutations are models of choice for the
study of neuropsychiatric conditions
We choose to study DISC1 for a number of reasons. First, a
translocation interrupting this gene is one of the ﬁrst identiﬁed
high penetrance mutations for common psychiatric outcomes.5
Second, other variants at this gene have been implicated across
neuropsychiatric disorders.13 Third, physical interactors of DISC1
have also been implicated in these disorders, suggesting that the
molecular mechanism modulated by DISC1 may be critical across
a number of disorders.7,14,32 There are several models of Disc1
mutants,29 and we decided to use L100P mutants, which present a
selective disruption of Disc1 interaction with selected molecules,
such as Pde4b and Gsk3β, which are also potential risk genes for
schizophrenia.20 We reasoned that as Pde4b is directly involved in
the metabolism of cAMP, an important mediator of CREB pathway
and activity-dependent development, these mutants may show
impairment in the formation and remodeling of circuitry. The
CREB pathway has been identiﬁed as an important modulator of
activity-dependent plasticity and learning abilities in several
organisms.33 Indeed we ﬁnd a correlation between impaired
activity-dependent changes and activation of CREB in L100P mice,
both in vitro and in vivo. Reduced CREB activity may impact both
Table 3. Immunostaining of LTD-treated and control cultures
Genotype Treatment Antigen n (cells) N (animals) Average s.e.
WT Control PSD95 28 3 1 0.07
WT LTD PSD95 28 3 1 0.01
L100P Control PSD95 20 5 1 0.06
L100P LTD PSD95 20 5 1 0.15
WT Control SYN 17 3 1 0.15
WT LTD SYN 17 3 0.95 0.2
L100P Control SYN 17 5 1 0.09
L100P LTD SYN 17 5 1.3 0.22
Abbreviations: LTD, long-term depression; SYN, synapsin; WT, wild type.
Figure 5. Alteration of PDE4B pathway in L100P mice. (a) PDE4B
immunostaining is increased in the brain of L100P mice. Represen-
tative images from PFC. (b) Quantiﬁcation of PDE4B staining across
different brain regions shows signiﬁcant increase of PDE4B
expression in L100P mice. (c) cAMP immunostaining is decreased
in the brain of L100P mice. Representative images from PFC. (d)
Quantiﬁcation of cAMP staining across different brain regions shows
a decreased trend of cAMP expression in L100P mice. Scale bar,
40 μm. *Indicates statistically signiﬁcant. PFC, prefrontal cortex; WT,
wild type.
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intrinsic and evoked excitability of the circuits33 and affect the
efﬁcacy of the communication from synapse to nucleus to synapse
communication18 (Supplementary Figure 8). There are several
cellular systems that ultimately activate CREB,31 and the main
effector is thought to be cAMP, whose concentration is regulated
by PDE4B.
In our study, we assess the role of Disc1 in activity-dependent
reorganization of circuitry in vivo. In addition, we show that some
deﬁcits in circuitry reorganization can be observed in vitro even at
early phases of postnatal development under appropriate
conditions.
In vivo, basal expression of PSD95 is signiﬁcantly downregulated
in the visual cortex of juvenile L100P animals (Figure 2), consistent
with the impairment of glutamatergic transmission reported in
schizophrenia and other disorders;12,34 this is conﬁrmed by
immunoblotting analysis of PSD95 on the whole brain. It is
possible that the expression of markers for synaptic and cellular
function changes according to brain region and developmental
stage; in fact, the PSD95 reduction is not visible at younger ages
(Supplementary Figure 7). After stimulation, L100P mutants fail to
respond to molecular and physiological changes induced by
activity in contrast to WT. Contrary to what was observed in basal
conditions in vivo, we did not ﬁnd any difference in control
expression levels of synaptic markers between L100P mutants and
WT in cultures (Supplementary Figure 4). This similarity in
expression levels can be due to in vitro preparation, to the young
age of the cultures (8–14 days in vitro) or to the brain area
selected. However, in vitro, LTP stimulation induces an effect in the
expression levels of synaptic markers in WT, but not L100P
cultures, hence Disc1 mutation is involved in the LTP-mediated
response.
We did not ﬁnd signiﬁcant changes with LTD stimulation,
suggesting that speciﬁc pathways are disrupted, at least in this
preparation.
In vivo and in vitro studies reveal overlapping phenotypes in
response to stimulation
Cultures prove to be good models to uncover morphological and
molecular abnormalities linked to DISC1 loss of function,12,35,36
and have the potential to reveal additional phenotypes in
response to stimulation protocols that cannot be performed
in vivo. Our experiments on the properties of circuitry in L100P
mutant preparations suggest a new interpretation of circuit
function in neuropsychiatric disorders: even if there is no
physiological difference in the basal conditions of the circuitry
between mutants and WT, challenging the system can reveal
distinct phenotype, suggesting that cultures still retain the
machinery to respond to activity but the underlying mechanisms
are altered in L100P mutants even at initial phases of develop-
ment. This may be important in modeling the dynamic processes
that are likely to contribute to the etiology of neuropsychiatric
disorders, and has a potential application to several cellular
preparations: from primary neuronal cultures in mice to neuronal
cells derived from patients. Consistent with the results in vitro, the
physiological status of L100P juvenile mice were not altered
in vivo, as we did not detect any impairment in the visual ability or
cortical-evoked signal; however, these mutant mice were not able
to respond to MD in the manner of WT controls (Figure 1). To our
knowledge, this is the ﬁrst study showing that appropriate
stimulation conditions can uncover cellular phenotypes, not
evident under basal conditions, even at early stages of develop-
ment and in such cellular preparations.
Mediators of molecular and functional phenotype in DISC1
mutants
The past decades have identiﬁed many molecular effectors of
neuropsychiatric disorders to be involved in synaptic function.
This aspect is indeed crucial for the adaptation of the brain
circuitry to the changing environment and it is therefore expected
that this phenotype would be impaired in neuropsychiatric
conditions. There are several levels at which the circuitry could
fail in responding to the extracellular signals: (1) communication
between synapse and nucleus, (2) reorganization of synapses, (3)
control of gene expression. DISC1, with its numerous interactors
and molecular functions, is possibly involved in all these steps. In
particular, the L100P mutants have impaired interactions with
Pde4B and Gsk3β, which have both shown to be involved in
activity-dependent reorganization of the synapses. Pde4B mod-
ulates the interplay between Disc1 and CREB activation.
In our mutants, the Disc1 protein is unable to interact properly
with Pde4B, leading to an increased degradation of cAMP, and as
a consequence, the level of PCREB is decreased. Indeed
histochemical analysis of Pde4B and cAMP levels in prefrontal
cortex reinforce the ﬁnding that the cAMP–CREB pathway is
disrupted (Figure 5). However, it is possible that the mechanisms
leading to CREB phosphorylation are different in different brain
areas, and that phosphodiesterases are also involved in the
balance of CREB activation.29,37 We cannot exclude that there
could be different mechanisms that mediate the limited plasticity
in L100P mice: Wei et al.38 report that in vitro, silencing Disc1
causes an increase of NMDAR activation. The constant upregula-
tion of activity may cause a homeostatic imbalance that impairs
the ability of mutant cells to respond to changes of activity. Also,
the role of Disc1 at the synapse has been reported by other
studies that show the modulation of glutamatergic components
via interactions with TNIK and Kalirin7;39,40 however, in our
mutants these are possibly indirect interactions as the mutated
site in Disc1 protein is different from that affected in L100P mice.
Another possible mechanism that explains L100P dysfunction is
the impairment of Gsk3B, with its consequences on PSD95
distribution. Gsk3β activating pathways are involved in the
localization of PSD95 to synapses in response to neuronal
stimulation.41 The localization of PSD95 at excitatory synapses is
directly correlated to synaptic strength42 and has a functional
consequence with the glutamatergic impairment in psychosis.34
The impairment of PSD95 but not SYN, which we ﬁnd in our in vivo
preparations, can be directly correlated to this pathway as a
consequence of the disruption of Gsk3β pathway, and can be
related to deﬁcits in synapses strengthening, rather than
formation. In fact, not only the presynaptic expression of synapsis
is related to both excitatory and inhibitory synapses, pointing at a
possible imbalance between gabaergic and glutamatergic trans-
mission, but SYN puncta are also associated to newly formed
synaptic boutons, which appear even before the postsynaptic
elements are assembled and can disappear if the synapse is not
strong enough to be maintained. These additional mechanisms
will need to be analyzed in detail in the following-up studies,
considering cell-speciﬁcity and developmental stage.
The expression of molecular markers adapts through
development to compensate the alteration in basal expression
levels
Considering that the L100P system was shown to be less reactive
to stimulation challenges right after birth and in juvenile animals,
we examined the expression of cellular and synaptic markers
during development in WT and L100P mice, ﬁnding a speciﬁc
pattern for different markers: although PCREB expression does not
change over time between WT and L100P, the ﬁnding that the
overexpression of presynaptic markers at the time of synapse
formation is followed by a progressive decay at following stages of
development suggests that the system tends to adapt to the initial
bias compensating the excess with a subsequent decrease at the
time of pruning. A consequence of the deﬁcits in presynaptic
markers can be the deﬁcit in presynaptic release observed in other
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Disc1 mutants which also impact NMDA activation.38,43 Even
considering that the results may be different in speciﬁc brain
areas, and that the information is lost in whole-brain homo-
genates, these results have profound implications that extend to
the general biology of neuropsychiatryc disorders and deserve to
be further studied considering other mutants.
We suggest that under normal developmental conditions, the
system adjusts to the genetic mutation with compensatory
mechanisms;44 however, when the system is challenged, these
mechanisms do not sufﬁce and mutants manifest an altered
response. It is possible that the initial impairment will be rectiﬁed
in the longer term by compensatory mechanisms. This explana-
tion is consistent with the impaired short-term plasticity observed
in other mice mutants for Disc1.29
Plasticity for discovering hidden phenotypes in neuropsychiatric
conditions
Interestingly, even before circuitry has reached maturation, stimuli
used to induce circuitry reorganization may be used to uncover
the phenotype. Of particular interest are in vivo forms of plasticity
such as visual cortical plasticity. Even if patients with neuropsy-
chiatric disorders do not have apparent deﬁcits in visual function,
there is growing evidence that visual perception is altered in
schizophrenia,45 and visual system plasticity has been used in
other neurodevelopmental disorders to uncover the biology of the
disease and to test possible treatments.46,47 Indeed, there is
agreement that the visual system is a choice model for studying
the reorganization of circuitry in vivo.23 These observations
suggest that future studies comparing mutations of different
severity, or assays representing variable mutation burden, may be
useful for modeling neuropsychiatric phenotypes. Interestingly,
we did not observe any phenotype in response to LTD in vitro,
suggesting that the mechanisms evoked by LTP and LTD are
different, and therefore only speciﬁc forms of stimulation will
reveal the dysregulation induced by mutant genes, according to
the mechanisms in which the genes are involved or the area of
investigation.48
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